Reistone Biopharma Company Limited is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative medications for immune-inflammatory ailments with unmet medical requirements. Crafting treatments for ailments necessitates fresh methods and effective cooperation among researchers, industry, regulatory bodies, and patient coalitions. Reistone is established from the firm's intimate partnerships with essential stakeholders and prominent pharmaceutical enterprises, and is committed to translating recent biotech understandings into revolutionary medicine for notable unmet medical requirements in China as well as worldwide.